Brind.

A research team led by Young Il Park at the Korea Research Institute of Chemical Technology is collaborating with Sung-Jin Park, with FDA approval being relevant for the US market.

1 report, 1 independent Updated Jul 24

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Korea Research Institute of Chemical Technology FDA

Keep exploring

The entities involved

Korea Research Institute of Chemical Technology
Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Jul 24newswise.com